Crossmark

SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart

Crossref DOI link: https://doi.org/10.1186/s12933-019-0816-2

Published Online: 2019-02-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Chenguang

Zhang, Jie

Xue, Mei

Li, Xiaoyu

Han, Fei

Liu, Xiangyang

Xu, Linxin

Lu, Yunhong

Cheng, Ying

Li, Ting

Yu, Xiaochen

Sun, Bei

Chen, Liming
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81470187, 31800722)

Natural Science Foundation of Tianjin (15ZXHLSY00460, 18JCYBJC26100, 18JCZDJC35500)
License Information

Text and Data Mining valid from 2019-02-02
More Information

Article History

Received: 12 November 2018

Accepted: 17 January 2019

First Online: 2 February 2019